Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Audentes Therapeutics Inc
BOLD | US
1.43
USD-0.01
-0.69%
BOLD | US
About Audentes Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
1.43
Open
1.42
High
1.44
Low
1.41
View Less
BOLD | US
Risk
46.3
Sharpe
0.47
Luna's Score
49/100
Recommendation
Hold
Luna says (BOLD | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
20.6%1 month
46.3%3 months
75.1%6 months
61.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.45
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-64.01M
MarketCap
37.46M
MarketCap(USD)
37.46M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-35.74
Short ratio
10.24
Short perc.
4.34
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.13
Range1M
0.27
Range3M
0.61
Volumes: Market Activity
Rel. volume
0.22
Price X volume
39.47K
